Public Health
A universal flu vaccine has aced phase 1 trials
Influenza’s constant genetic shifting means flu vaccines aim at a moving target. But a universal flu vaccine just passed its phase 1 trials.
HIV can hide inside human cells for years. Can CRISPR cut it out?
Using CRISPR to stop the replication of SIV, a primate virus closely related to HIV, researchers may have taken a step to wiping the virus out in the body.
FDA authorizes first over-the-counter COVID-19 test
The FDA has authorized the first over-the-counter COVID-19 test for home use, but buyers still have to send their samples to a lab for processing.
The quest for a “warm” COVID-19 vaccine
Developers are on the hunt for a warm COVID-19 vaccine, one that could be distributed in places where a reliable cold chain isn’t available.
Congo just used vaccines to beat Ebola. What they learned could stop COVID, too.
Congo’s recent success delivering frigid Ebola vaccines to remote areas may provide invaluable experience for a COVID-19 vaccine cold chain.
When will we have a COVID-19 vaccine?
Several developers have reported incredible coronavirus vaccine progress, so when will we have a COVID-19 vaccine ready for distribution?
Reverse engineering a $15k medical device for 50x less
Many hospitals in developing countries can’t access the overpriced, high-tech equipment that’s standard in the U.S. Reverse innovation could finally change that.
Oxford says its COVID-19 vaccine is up to 90% effective
The University of Oxford's COVID-19 vaccine was up to 90% effective in a phase 3 trial and could be easier to distribute than other coronavirus vaccines.
How long will coronavirus immunity last?
Coronavirus immunity might last for years, according to a new study that measured the levels of virus-fighting immune cells in COVID-19 survivors.
FDA authorizes first at-home COVID-19 test
The FDA has authorized an at-home COVID-19 test that delivers results in 30 minutes, but you can’t get it without a prescription.